Competitor News, Product Updates

Komodo Health Introduces the First Integrated Patient Insurance Dataset to Enhance Patient-Level Insights for Life Sciences

June 12, 2024 08:00 AM Eastern Daylight Time SAN FRANCISCO–(BUSINESS WIRE)–Today, Komodo Health launches Komodo Patient Insurance™ (KPI), a first-of-its-kind data offering featuring in-depth insights into the insurance status of more than 200 million de-identified U.S. patient lives. With this news, Komodo introduces the most comprehensive resource to accurately identify…

Competitor News, Fundraising/IPO

Real World Health (t/a RwHealth) secures £1.37 million Series A Follow On investment led by Maven Capital Partners 

Real World Health Raises £1.37m To Help NHS Maximise Value of Data to Improve Patient Care LONDON, 12th June 2024 – Real World Health has closed a £1.37 million funding round to help the NHS make better use of its data and address critical challenges like surgery backlogs and mental health. The funding round…

Competitor News, Product Updates

HealthVerity Enhances Provider Diversity and Diagnosis Index with AnalyticsIQ Ethnicity Insights

HealthVerity to offer AnalyticsIQ race and ethnicity data linked to over 2 million NPIs We are now able to provide insights into the race and ethnicity of approximately 85% of all healthcare providers in the nation’s largest healthcare data ecosystem.” — Andrew Kress, HealthVerity CEOPHILADELPHIA, PA, UNITED STATES, June 4,…

Collaborations, Competitor News

ConcertAI to Advance Translational and Clinical Development Solutions in Collaboration with NVIDIA

CAMBRIDGE, Mass., June 2, 2024 /PRNewswire/ — ConcertAI, the leading oncology real-world evidence data and AI SaaS technology company, today announced a collaboration with NVIDIA to advance a broad set of translational and clinical development solutions within the ConcertAI CARA AI platform. This collaboration leverages NVIDIA Inference  microservices (NIM), including the recently published Llama 3 NIM,…

Competitor News, Fundraising/IPO

Atropos Health Raises $33M to Scale the Automation of High-Quality, Personalized Real-World Evidence Leveraging Generative AI

The Company is Also Forging Strategic Partnerships With Pharmaceutical Companies and Vertically Integrated Healthcare Companies to Drive Evidence Adoption in Oncology and other Specialty areas May 23, 2024 09:24 AM Eastern Daylight Time PALO ALTO, Calif.–(BUSINESS WIRE)–Atropos Health, the pioneer in translating real-world clinical data into high-quality personalized real-world evidence…

AI, Collaborations, Competitor News, Data Partnership, Events, Marketing, Product Updates

ConcertAI introduces predictive and generative AI solutions powered by multi-modal real-world data, key partnerships, CARA AI, and more at the 2024 ASCO Annual Meeting

Solutions enable both research and clinical teams with precision oncology, accelerating clinical trials, increasing patient access, and driving improved patient outcomes CAMBRIDGE, Mass., May 31, 2024 /PRNewswire/ — ConcertAI, a leader in oncology predictive and generative AI SaaS and real-world data (RWD) solutions for healthcare and life sciences, today announces first-in-category predictive and…

Collaborations, Competitor News, Government/Regulatory

COTA Announces Extended Collaboration with FDA to Advance the Use of Real-World-Data in Cancer Research

May 22, 2024 09:00 AM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)–Today, COTA announced an extension of its research collaboration with ​​the U.S. Food and Drug Administration’s (FDA) Oncology Center of Excellence. Under the collaboration, the two organizations will continue to jointly develop and implement research projects to advance the use…

Competitor News, Product Updates

Syapse Expands Oncology Real-World Data Offerings with Introduction of Syapse Cohorts: Essentials

WEST CHESTER, Pa., May 22, 2024 (GLOBE NEWSWIRE) — Syapse, a leading real-world oncology data company announced the launch of its latest real-world data offering: Syapse Cohorts: Essentials. This new offering expands upon Syapse’s existing offering of Enriched Cohorts, and is designed to empower cancer researchers and life sciences companies with unparalleled insights…